ChargePoint Technology and STERIS collaborate to bring sterile solutions for Evonik
Evonik will be provided with sterile solutions from a collaboration between ChargePoint Technology Group and STERIS, utilising ChargePoint’s AseptiSafe Bio Valve and STERIS’ bio-decontamination systems.
Powder and liquid transfer specialists ChargePoint Technology Group (Liverpool, UK) have partnered with STERIS (Mentor, USA), providers of infection prevention and other procedural products and services, to bring a successful sterile solution to chemicals company Evonik (Essen, Germany).
At its plant in Alabama, USA, Evonik manufactures complex parenteral medications using fill-finish lines handling a broad mix of products. Evonik will be utilising ChargePoint’s AseptiSafe® Bio Valve, which will be coupled to the STERIS Vaporised Hydrogen Peroxide bio-decontamination system. Optimised for continuous filling, the line will allow chemical products to move through processes rapidly and efficiently. Product transfer from a container to filling equipment maintained in a sterile environment will also be achieved through the solution. In addition, the ChargePoint AseptiSafe Split Butterfly Valve will securely connect the product and the container, further protecting sterility and the integrity of the API.
CEO of ChargePoint Technology Chris Eccles commented: “With the development of specialised medicines increasing, many manufacturers like Evonik have struggled to find specialised equipment that meet their requirements. It was absolutely crucial that Evonik could aseptically connect and disconnect the product vessel quickly to maintain product sterility. After reviewing multiple vendors, our system was found to provide the highest degree of product protection.”
The VHP 1000ED bio-decontamination unit from STERIS possesses the ability to decontaminate its surroundings and adapts easily to the manufacturing environment. By combining the abilities of ChargePoint and STERIS’ technologies, replacing product containers during manufacturing can occur aseptically within 1 hour while enabling continuous filling, further minimising downtime.
Caroline Hand, Production Engineer at Evonik, stated: “Evonik has been delighted by the results produced the multifaceted approach from ChargePoint and STERIS This partnership provided a solution that delivered the highest integrity when performing high volume aseptic product transfer with multiple product containers and significantly reduced the turnaround time of this project. We are thrilled with the outcomes.”
Associate Product Manager Abby Lovell from STERIS added: “Our continued partnership with ChargePoint means that its unique aseptic SBV technology in conjunction with STERIS’ VHP bio-decontamination system are collectively meeting the technical needs of the industry. This has allowed us to provide the ultimate sterile transfer solution to Evonik and we look forward to many more years of partnership.”
Related News
-
News Pharmapack Awards 2024 Patient-Centric Design Award Winner – Dr Ferrer BioPharma
The 2024 Pharmapack Awards celebrated the best in innovation and design for the pharmaceutical packaging and drug delivery industry on January 24, 2024. -
News Women in Pharma: Minding the Gap at Pharmapack 2024
2024 marks the first year Pharmapack will host a Diversity track dedicated to bridging the gap within the pharmaceutical packaging and drug delivery sector. The track includes a panel discussion on 'Enabling Diversity in the Workplace,' focused... -
News Pharmapack Awards 2024 - Celebrating Packaging and Drug Delivery Innovation
The 2024 Pharmapack Innovation Awards ceremony celebrated the best in pharmaceutical packaging and drug delivery innovation at all levels. The awards were held on January 24, 2024 at the Paris Expo Porte de Versailles. -
News 2024 Pharma Industry Trends Outlook: Collaboration, Market Maturity, and Digital Futures
The annual CPHI Online 2024 Pharma Trends Outlook, in partnership with Arvato Systems, identifies 12 key industry trends shaping the life sciences industry in the coming year. -
News New Novo Nordisk AI hub for drug discovery to open in London, UK
Danish pharmaceutical giant Novo Nordisk will be opening an AI-based research facility in the heart of London to advance drug discovery operations. -
News BioNTech to begin mRNA vaccine manufacturing in Rwanda by 2025
German biotechnology company BioNTech has stated their intentions to begin production at their mRNA vaccine factory in Rwanda by 2025, which will mark the first foreign mRNA vaccine manufacturing site on the continent of Africa. -
News Women in Pharma: Looking back on 2023 and moving forward to 2024
In this monthly series, we interview women from across the pharmaceutical industry and supply chain to discuss the importance of gender diversity in healthcare, the workplace, and beyond. -
News CPHI Barcelona 2023: Partnering for Success – Managing Outsourcing Relationships to Optimise Manufacturing Operations
During CPHI Barcelona 2023, insightful content sessions offered attendees the chance to explore trending topics with expert speakers and panellists. Here, we summarise what the pharma industry and supply chain are talking about the most.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance